Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Advances in Radiation Oncology
|
June 14, 2017
Analysis of patient outcomes following proton radiation therapy for retinoblastoma
Kent W Mouw, Beow Y Yeap, Paul Caruso, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel
Kendrick Yim, Matias Vergara, Jihyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Kent W Mouw, James M Cleary, Brendan Reardon, et al.
The Journal of Clinical Investigation
|
September 23, 2021
RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics
Raie T Bekele, Amruta S Samant, Amin H Nassar, et al.
European Urology
|
February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology
|
October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
David D Yang, Leslie K Lee, James M G Tsui, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
Amin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Molecular Cancer Research : MCR
|
February 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes
Elio Adib, Amin H Nassar, Sarah Abou Alaiwi, et al.
British Journal of Cancer
|
December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
Amin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
JCO Precision Oncology
|
July 1, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601
Gopa Iyer, Woonyoung Choi, Bin Luo, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Advances in Radiation Oncology
|
June 14, 2017
Analysis of patient outcomes following proton radiation therapy for retinoblastoma
Kent W Mouw, Beow Y Yeap, Paul Caruso, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel
Kendrick Yim, Matias Vergara, Jihyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
Kent W Mouw, James M Cleary, Brendan Reardon, et al.
The Journal of Clinical Investigation
|
September 23, 2021
RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics
Raie T Bekele, Amruta S Samant, Amin H Nassar, et al.
European Urology
|
February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A Mahal, David D Yang, Natalie Q Wang, et al.
Radiology
|
October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
David D Yang, Leslie K Lee, James M G Tsui, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 18, 2019
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
Amin H Nassar, Sarah Abou Alaiwi, Saud H AlDubayan, et al.
Molecular Cancer Research : MCR
|
February 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes
Elio Adib, Amin H Nassar, Sarah Abou Alaiwi, et al.
British Journal of Cancer
|
December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
Amin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
JCO Precision Oncology
|
July 1, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601
Gopa Iyer, Woonyoung Choi, Bin Luo, et al.
Page
of 13